Skip to content
Field Notes

The research side of permaculture.studio.

Verification record

Every claim in this article was checked against the abstracts of the papers it cites, by a separate pass that was given those abstracts and nothing else. A claim marked supported carries the sentence that supports it, quoted verbatim below.

References
14
Claims checked
6
Fully supported
4
Checked on
Sep 28, 2026

Claim by claim

  1. A systematic review of adults published between January 2023 and October 2025 identified 12 full-text studies of molecular UTI diagnostics, including only two randomised controlled trials.

    Partially supportedMeta-analysisMeta-analysis

    “A systematic review was conducted for articles in adults from January 2023 to October 2025 as an update to previous scoping reviews.”

    The systematic review itself was published in 2026 and examined articles published between January 2023 and October 2025, and the claim combines details spread across multiple sentences of the abstract.

    Checked by google/gemini-3.8-flash on Sep 28, 2026

  2. In those two RCTs, which enrolled 773 patients who were mostly female and over 65, PCR-based testing was more sensitive than standard urine culture but lacked specificity.

    SupportedMeta-analysisMeta-analysis

    “Two clinical studies were randomized controlled trials (RCTs) which included a total of 773 patients, mostly female and above the age of 65. Compared to a standard urine culture, molecular based testing, specifically with polymerase chain reaction (PCR) testing yielded superior sensitivity despite lack of specificity and guided antibiotic therapy to reduce UTI baseline symptomatology in the short term (i.e. 28 days) in both RCT analyses.”

    The abstract directly confirms the sample size, demographic characteristics, and diagnostic performance of PCR testing relative to standard urine culture across the two RCTs.

    Checked by google/gemini-3.8-flash on Sep 28, 2026

  3. Both RCTs and five of ten prospective studies were funded by the companies that developed the molecular tests.

    SupportedMeta-analysisMeta-analysis

    “the RCT analyses and several of the prospective studies (5/10) were funded by the companies that developed the molecular tests”

    The text confirms that the RCT analyses (earlier identified as two clinical studies) and 5 of 10 prospective studies were funded by the test developers.

    Checked by google/gemini-3.8-flash on Sep 28, 2026

  4. The review reports that PCR-guided antibiotic therapy reduced UTI symptoms at 28 days in both RCTs, and describes clinical outcome data overall as limited.

    SupportedMeta-analysisMeta-analysis

    “molecular based testing, specifically with polymerase chain reaction (PCR) testing yielded superior sensitivity despite lack of specificity and guided antibiotic therapy to reduce UTI baseline symptomatology in the short term (i.e. 28 days) in both RCT analyses. Of note, the RCT analyses and several of the prospective studies (5/10) were funded by the companies that developed the molecular tests. CONCLUSIONS: Based on the increase in publications over the last three years, new industry-funded RCTs, and the limited clinical outcome data reported”

    The review directly notes that PCR-guided therapy reduced UTI symptoms at 28 days across both RCTs and describes the reported clinical outcome data as limited.

    Checked by google/gemini-3.8-flash on Sep 28, 2026

  5. qPCR detects DNA from viable, dead, damaged or lysed cells and from extracellular DNA, so a positive signal does not establish living bacteria.

    Partially supportedUnclassifiedUnclassified. The study design could not be determined automatically.

    “qPCR detects DNA originating from viable, dead, damaged, or lysed cells, as well as extracellular DNA (eDNA).”

    The abstract confirms that qPCR detects DNA from all these cellular states and extracellular sources, but it does not explicitly state the concluding clause that a positive signal does not establish living bacteria.

    Checked by google/gemini-3.8-flash on Sep 28, 2026

  6. A locally derived virulence-gene definition of uropathogenic E. coli outperformed published nonlocal definitions in isolates from semi-rural Ecuador, but still reached only 56.2% sensitivity.

    SupportedCohort studyCohort study

    “The optimal local definition for ESBL-producing UPEC was the presence of ≥ 1 of upaH , cnf1 , or sat (Youden’s index = 0.505, 95% CI: 0.416, 0.596; sensitivity = 56.2%, 95% CI: 47.5, 64.7; specificity = 94.3%, 95% CI: 89.8, 97.2), which showed better diagnostic performance among isolates than nonlocal definitions of UPEC (YI ranged from 0 to 0.361).”

    The study confirmed that the locally derived definition outperformed nonlocal definitions in local isolates while achieving 56.2% sensitivity.

    Checked by google/gemini-3.8-flash on Sep 28, 2026

What this does and does not prove

It proves that every DOI cited resolves to a real registered work whose returned DOI matches the one requested, that none of them is retracted, and that each claim has a named sentence in a cited abstract behind it.

It does not prove that the paper as a whole supports the claim. An abstract can overstate its own findings, and a sentence can be read out of context. That is why the quote is printed here rather than summarised: if the check is wrong, you can see that it is wrong.

Evidence grading is automatic and conservative. Anything it cannot classify is marked unclassified rather than flattered upward.